The effect of revascularization in patients with anatomically significant atherosclerotic renovascular disease presenting with high-risk clinical features
Author(s) -
Diana Vassallo,
James Ritchie,
Darren Green,
Constantina Chrysochou,
Philip A. Kalra
Publication year - 2017
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfx025
Subject(s) - medicine , revascularization , cardiology , disease , atherosclerotic cardiovascular disease , arterial disease , vascular disease , myocardial infarction
Patients with atherosclerotic renovascular disease (ARVD) and high-risk clinical presentations have largely been excluded from randomized controlled trials comparing renal revascularization and optimal medical therapy. Here, we explore the effect of revascularization on death, progression to end-stage kidney disease (ESKD) and cardiovascular events (CVE) in a highly selected cohort of patients with ARVD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom